Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

Page 26 of 100

BeiGene FDA Approval Cancer

Chinese Biotech BeiGene Makes a Splash in Cancer Treatment With FDA Drug Approval

By Sy Mukherjee

Superbugs Infecting Millions CDC

The Tiny Problem Sickening Millions of Americans

By Sy Mukherjee

President Trump Will Meet With the Vaping Industry Ahead of Potential Bans

By Sy Mukherjee

Merck Ebola Vaccine Approved

Merck Wins European Approval for World’s First-Ever Ebola Vaccine

By Sy Mukherjee

Vaping Illness Chemical Cause CDC

CDC Homes In on the Chemical Villain Causing Mysterious Vaping Illnesses

By Sy Mukherjee

CRISPR Gene Editing Cancer Safety

CRISPR Gene-Editing Is Being Used to Fight Cancer—And May Be Safe

By Sy Mukherjee

Apple VA Veterans iPhone Health Records

Apple Teams Up With VA to Let Veterans Access Health Records Via iPhone

By Sy Mukherjee

Juul Labs Inc. E-Cigarettes As Altria Deal Signals Doubt In Future

Former FDA Chief Says Juul Created a Youth Vaping ‘Crisis’

By Sy Mukherjee

Bill Gates Alzheimers Part the Cloud

Bill Gates Commits $10 Million More for Alzheimer’s Research to ‘Part the Cloud’

By Sy Mukherjee

Google Fitbit Acquisition Takeaways

3 Key Takeaways from Google’s Fitbit Acquisition

By Sy Mukherjee

Amgen BeiGene China Bitoech

U.S. Biotech Amgen Strikes Major Deal to Expand China Presence

By Sy Mukherjee

Hims & Hers Recruits Cleveland Clinic Vet Toby Cosgrove: Brainstorm Health

By Sy Mukherjee

Toby Cosgrove Hims and Hers Board

Exclusive: Former Cleveland Clinic CEO Toby Cosgrove Joins Telehealth Firm Hims & Hers Board

By Sy Mukherjee

Juul Management Shakeup

Juul Replaces CFO as Part of Major Management Shakeup: Brainstorm Health

By Sy Mukherjee

Facebook Preventive Health Tool

Facebook Just Launched a New Preventive Health Tool: Brainstorm Health

By Sy Mukherjee